Following the guidelines of this proposal of the international EDS Consortium [8], we genetically examined the patient and consequently identified that she had a missense mutation in the COL3A1 gene (c.2095G>T, p.Gly699Cys). This evidence concerns the gene COL3A1 and Ehlers-Danlos syndrome.